5D8-60467-33046
3 vaccinations
3 coded responses
40 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 152 / PA
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Registered in v-safe
-
2021-01-30
Dose 1 — Moderna
- 2021-01-30
-
2021-01-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
- 2021-02-20
-
2021-02-27
Dose 2 — Moderna
- 2021-02-27
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-05-29
- 2021-08-28
-
2021-11-01
Dose 3 — Moderna
-
2021-11-01
Health check-in — day 0, dose 3Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
-
2022-01-31
Survey response — 3 months, dose 3MedDRA: Anosmia, Exposure to SARS-CoV-2, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: GoodFree text: Mild sore throat, slight loss of smell. Wife and child both tested positive for COVID, I tested negative repeatedly.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-02
Survey response — 6 months, dose 3MedDRA: Exposure to SARS-CoV-2, Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test negative — Feeling: GoodFree text: Slight persistent sore throat/cold symptoms, and family tested positive for COVID. I tested multiple times, both PCR and rapid tests, never tested positive myself.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-03
Survey response — 12 months, dose 3MedDRA: Influenza, Nasopharyngitis, Oropharyngeal pain, Respiratory disorder, Respiratory tract congestion — Feeling: GoodFree text: General cold/flu symptoms, sore throat, congestion. Nothing too serious, but typical seasonal respiratory illness symptoms.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Moderna | |
| 2 | 2021-02-27 | Moderna | |
| 3 | 2021-11-01 | Moderna | No |
Free text
Release 11 — 3 months, dose 3
Symptoms: Mild sore throat, slight loss of smell. Wife and child both tested positive for COVID, I tested negative repeatedly.
Release 11 — 6 months, dose 3
Symptoms: Slight persistent sore throat/cold symptoms, and family tested positive for COVID. I tested multiple times, both PCR and rapid tests, never tested positive myself.
Release 12 — 12 months, dose 3
Symptoms: General cold/flu symptoms, sore throat, congestion. Nothing too serious, but typical seasonal respiratory illness symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release